Colloids for the initial management of severe sepsis and septic shock in pediatric patients a systematic review

Pediatric Emergency Care

Volumn 31, Issue 11, 2015, Pages e11-e16

  Medeiros, Daniela Nasu Monteiro ^a,b   Ferranti, Juliana Ferreira ^a   Delgado, Artur Figueiredo ^c   De Carvalho, Werther Brunow ^c  

^a Hospital Municipal Dr Moisés Deutsch M Boi Mirim   (Brazil)

^b HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^c Pediatric Intensive Care Department   (Brazil)

Author keywords

Colloid; Crystalloid; Sepsis

Indexed keywords

BURN; CHILD; COLLOID; CRYSTALLOID; DENGUE SHOCK SYNDROME; DIET THERAPY; FEVER; FLUID RESUSCITATION; HEART SURGERY; HUMAN; INTESTINE INFECTION; MALARIA; MENINGITIS; PEDIATRICS; PNEUMONIA; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEPSIS; SEPTIC SHOCK; SKIN INFECTION; SOFT TISSUE INFECTION; SYSTEMATIC REVIEW; PROSPECTIVE STUDY; SHOCK, SEPTIC; THERAPEUTIC USE;

COLLOID;

CHILD; COLLOIDS; HUMANS; PROSPECTIVE STUDIES; SEPSIS; SHOCK, SEPTIC;

EID: 84988923715     PISSN: 07495161     EISSN: 15351815     Source Type: Journal    
DOI: 10.1097/PEC.0000000000000601     Document Type: Review

References (39)

1. Han YY, Carcillo JA, Dragotta M.A., et al. Early reversal of pediatric-neonatal septic shock by community physicians is associated with improved outcome. Pediatrics. 2003; 112:793-799.
2. Vincent JL, Gerlach H. Fluid resuscitation in severe sepsis and septic shock: an evidence-based review. Crit Care Med. 2004; 32(11 suppl): S451-S454.
3. Potério G.M.B., Braga AA, Vane LA Tratado de anestesiologia da SAESP, 6th ed, Editora Atheneu: São Paulo, Brazil, 2006.
4. McClelland DB. Safety of human albumin as a constituent of biologic therapeutic products. Transfusion. 1998; 38:690-699.
5. Boldt J, Suttner S. Plasma substitutes. Minerva Anesthesiol. 2005; 71: 741-758.
6. Quinlan GJ, Martin GS, Evans TW Albumin: biochemical properties and therapeutic potential. Hepatology. 2005; 41:1211-1219.
7. Bailey AG, McNaull PP, Jooste E, et al Perioperative crystalloid and colloid fluid management in children: where are we and how did we get here? Anesth Analg. 2010; 110:375-390.
8. Higgins JP, Altman DG, Gøtzsche PC, et al.; Cochrane Bias Methods Group; Cochrane Statistical Methods Group. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011; 343:d5928.
9. Ngo NT, Cao XT, Kneen R. Acute management of dengue shock syndrome: a randomized double-blind comparison of 4 intravenous fluid regimens in the first hour. Clin Infect Dis. 2001; 32:204-213.
10. Dung NM, Day NP, Tam D.T., et al. Fluid replacement in dengue shock syndrome: a randomized, double-blind comparison of four intravenous-fluid regimens. Clin Infect Dis. 1999; 29:787-794.
11. Maitland K, Pamba A, English M., et al. Randomized trial of volume expansion with albumin or saline in children with severe malaria: preliminary evidence of albumin benefit. Clin Infect Dis. 2005; 40:538-545.
12. Cifra HL, Velasco JNJ. A comparative study of the efficacy of 6% Haes-Steril and Ringer's Lactate in the management of dengue shock syndrome 555. Critical Care and Shock. 2003; 2:95-100.
13. Maitland K, Pamba A, Newton C.R., et al. Response to volume resuscitation in children with severe malaria. Pediatr Crit Care Med. 2003; 4:426-431.
14. Upadhayay M, Singhi S, Murlidharan J., et al. Randomized evaluation of fluid resuscitation with crystalloid (saline) and colloid (polymer from degraded Gelatin in saline) in pediatric septic shock. Indian Pediatr. 2005; 42:223-231.
15. Maitland K, Pamba A, English M., et al. Pre-transfusion management of children with severe malarial anaemia: a randomised controlled trial of intravascular volume expansion. Br J Haematol. 2005; 128: 393-400.
16. Wills BA, Nguyen MD, Ha T.L., et al. Comparison of three fluid solutions for resuscitation in dengue shock syndrome. N Engl J Med. 2005; 353(9): 877-889.
17. Akech S, Gwer S, Idro R., et al. Volume expansion with albumin compared with gelofusine in children with severe malaria: results of a controlled trial. PLoS Clin Trials. 2006; 1:e21.
18. Akech SO, Jemutai J, Timbwa M., et al. Phase II Trial on the use of dextran 70 or starch for supportive therapy in Kenyan children with severe malaria. Crit Care Med. 2010; 38:1630-1636.
19. Akech SO, Karisa J, Nakamya P., et al. Phase II trial of isotonic fluid resuscitation in Kenyan children with severe malnutrition and hypovolaemia. BMC Pediatrics. 2010; 10:71.
20. Maitland K, Kiguli S, Opoka R.O., et al.; FEAST Trial Group. Mortality after fluid bolus in African children with severe infection. N Engl J Med. 2011; 364:2483-2495.
21. Brierly J, Carcillo JA, Choong K, et al Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine. Crit Care Med. 2009; 37:666-688.
22. Bagshaw SM, Bellomo R. The influence of volume management on outcome. Curr Opin Crit Care. 2007; 13:541-548.
23. Ranjit S, Kisson N, Jayakumar I. Aggressive management of dengue shock syndrome may decrease mortality rate: a suggested protocol. Pediatr Crit Care Med. 2005; 6:412-419.
24. Pollard AJ, Britto J, Nadel S., et al. Emergency management of meningococcal disease. Arch Dis Child. 1999; 80:290-296.
25. Paul M, Dueck M, Herrman JH A randomized, controlled study of fluid management in infants and toddlers during surgery: hydroxyethyl starch 6% (HES 70/0.5) vs lactated Ringer's solution. Paediatr Anaesth. 2003; 13:603-608.
26. Starling EH. On the absorption of fluids from the connective tissue spaces. J Physiol. 1896; 19:312-326.
27. Michel CC, Curry FE Microvascular permeability. Physiol Rev. 1999; 79:703-761.
28. Huxley VH, Curry FE Differential actions of albumin and plasma on capillary solute permeability. Am J Physiol. 1991; 260:H1645-H1654.
29. Belayev L, Saul I, Finotti N., et al. Neuroprotective effect of high-dose albumin therapy against global ischemic brain injury in rats. Brain Res. 1999; 845:107-111.
30. Reinhart WH, Nagy C. Albumin affects erythrocyte aggregation and sedimentation. Eur J Clin Invest. 1995; 25:523-528.
31. Bayer O, Reinhart K, Sakr Y., et al. Renal effects of synthetic colloids and crystalloids in patients with severe sepsis: a prospective sequential comparison. Crit Care Med. 2011; 39:1335-1342.
32. Annane D, Siami S, Jaber S., et al.; CRISTAL Investigators. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA. 2013; 310:1809-17.
33. Guidet B, Martinet O, Boulain T., et al. Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study. Crit Care. 2012; 16:R94.
34. Perner A, Haase N, Guttormsen A.B., et al.; 6S Trial Group; Scandinavian Critical Care Trials Group. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med. 2012; 367:124-134 doi: 10.1056/NEJMoa1204242. Epub 2012 Jun 27.
35. Erratum in: N Engl J Med. 2012 Aug 2; 367(5):481.
36. Brunkhorst FM, Engel C, Bloos F., et al. German Competence Network Sepsis (SepNet). N Engl J Med. 2008; 358:125-139.
37. Ford S, Visram A. Mortality after fluid bolus in African children with sepsis. N Engl J Med. 2011; 365:1348.
38. Kissoon N, Carcillo JA; Global Sepsis Initiative of the World Federation of Pediatric Intensive and Critical Care Societies. Mortality after fluid bolus in African children with sepsis. N Engl J Med. 2011; 365:1350.
39. Hung NT. Fluid management for dengue in children. Paediatr Int Child Health. 2012; 32(suppl 1):39-42.